This handbook is the first to deal with the discovery of drugs targeted against apicomplexan parasites, a group of endoparasites that includes the causative agents of malaria, toxoplasmosis, and babesiosis, among others. Written by renowned scientific experts from academia and industry, the book focuses on current drug development approaches for all apicomplexan diseases, thus making it attractive to a large audience ranging from research labs in academia to the human and veterinarian pharmaceutical industry. It is the second volume in the new book series 'Drug Discovery in Infectious Diseases', edited by Prof. Paul M. Selzer.